Main Menu Browse by Day or Program Author Keywords

LB2 Late Breaker Oral Abstracts

Sunday, April 3, 2011: 2:15 PM-4:15 PM
Coronado BCD (Hilton Anatole)
Type: Late Breaking Abstracts
Moderators:
Gina Pugliese, RN, MS and C. Glen Mayhall, MD

2:15 PM
LB 9
Evaluation of sampling denominator data to estimate central line days: Validation of methods to reduce data collection burden of the National Healthcare Safety Network
Nicola D. Thompson, PhD, Centers for Disease Control and Prevention; Deborah Godine, RN, CIC, California EIP; Julie Duran, MPH, Colorado Department of Public Health and Environment; Deborah Thompson, MD, MSPH, FACPM, New Mexico Department of Health; Patricia Lawson, RN, MS, MPH, CIC, Maryland Department of Health & Mental Hygiene; Zintars Beldavs, MS, Oregon Health Department; Ghinwa Dumyati, MD, University of Rochester; Matthew B. Crist, MD, MPH, Tennessee Department of Health; Jonathan Edwards, MStat, Centers for Disease Control and Prevention; Shelley Magill, MD, PhD, Centers for Disease Control and Prevention
2:30 PM
LB 10
Preliminary Results of a Healthcare-Associated Infection and Antimicrobial Use Prevalence Survey in 22 U.S. Acute Care Hospitals
Shelley S. Magill, MD, PhD, Centers for Disease Control and Prevention; Laura M. Mcallister, MPH, Centers for Disease Control and Prevention; Kathy Allen-Bridson, RN, BSN, CIC, Centers for Disease Control and Prevention; Wendy Bamberg, MD, Colorado Department of Public Health and Environment; Joan Baumbach, MD, MS, MPH, New Mexico Department of Health; Zintars Beldavs, MS, Oregon Department of Human Services; Cathy Concannon, University of Rochester; Matthew B. Crist, MD, MPH, Tennessee Department of Health; Ghinwa Dumyati, MD, University of Rochester; Julie Duran, MPH, Colorado Department of Public Health and Environment; Jonathan Edwards, MStat, Centers for Disease Control and Prevention; Deborah Godine, RN, CIC, California Emerging Infections Program; Jane E. Harper, BSN, MS, CIC, Minnesota Department of Health; Katherine Henry, MPH, Maryland Department of Health and Mental Hygiene; Teresa Horan, MPH, CIC, Centers for Disease Control and Prevention; Marion A. Kainer, MBBS, MPH, Tennessee Department of Health; Patricia Lawson, RN, MS, MPH, CIC, Maryland Department of Health and Mental Hygiene; Ruth Lynfield, MD, Minnesota Department of Health; Monear Makvandi, MPH, New Mexico Department of Health; Richard Melchreit, MD, Connecticut Department of Public Health; Gloria Morrell, MSN, RN, Centers for Disease Control and Prevention; Joelle Nadle, MPH, California Emerging Infections Program; Melinda Neuhauser, PharmD, MPH, Centers for Disease Control and Prevention; Lewis Perry, RN, MPH, Georgia Emerging Infections Program; Jean Rainbow, RN, MPH, Minnesota Department of Health; Susan M. Ray, MD, Emory University School of Medicine; Arthur Reingold, MD, University of Berkeley; Richard Rodriguez, MPH, Connecticut Department of Public Health; Rebecca Smith, MPH, University of Rochester; Arjun Srinivasan, MD, Centers for Disease Control and Prevention; Ann Thomas, MD, Oregon Department of Human Services; Deborah Thompson, MD, MSPH, FACPM, New Mexico Department of Health; Nancy White, RN, Georgia Emerging Infections Program; Lucy Wilson, MD, ScM, Maryland Department of Health and Mental Hygiene; Scott K. Fridkin, MD, Centers for Disease Control and Prevention
2:45 PM
LB 11
Introducing a Population-Based Outcome Measure to Evaluate the Effect of Interventions to Reduce Catheter-Associated Urinary Tract Infection
Mohamad G. Fakih, MD, MPH, St John Hospital & Medical Center and Wayne State University School of Medicine; M. Todd Greene, PhD, MPH, University of Michigan Health System; Edward M. Kennedy, MS, VA Ann Arbor Health Care System and the University of Michigan Health System; Jennifer Meddings, MD, MS, University of Michigan Health System; Sarah L. Krein, PhD, RN, VA Ann Arbor Health Care System and the University of Michigan Health System; Russell N. Olmsted, MPH, CIC, St. Joseph Mercy Health System; Sanjay Saint, MD, MPH, VA Ann Arbor Health Care System and the University of Michigan Health System
3:00 PM
LB 12
Evaluation of the Relationship between Catheter-Associated Urinary Tract Infection Rates and Urinary Catheter Utilization Among Hospital Wards and Intensive Care Units Reporting to the National Healthcare Safety Network, January 2009-June 2010
Pritish K. Tosh, MD, Centers for Disease Control and Prevention; Jonathan Edwards, MStat, Centers for Disease Control and Prevention; Scott Fridkin, MD, Centers for Disease Control and Prevention; Carolyn V. Gould, MD, MSCR, Centers for Disease Control and Prevention
3:15 PM
LB 13
Incidence of qacA/B genes in Methicillin-resistant Staphylococcus aureus Isolated during 2010 in a Regional U.S. Surveillance Network
Patrick McGann, PhD, Walter Reed Army Institute of Research; Paige Waterman, MD, Walter Reed Army Institute of Research; James Cummings, MD, Walter Reed Army Institute of Research; David Craft, PhD, Walter Reed Army Institute of Research; Emil Lesho, DO, Walter Reed Army Institute of Research
3:30 PM
LB 14
Adverse Events Associated with Daily Chlorhexidine Gluconate (CHG) Bathing in Critically Ill Children: Result from a Multicenter, Cluster Randomized, Controlled, Crossover Trial
Aaron M. Milstone, MD, MHS, Johns Hopkins Medical Institutions; Alexis Elward, MD, Washington University School of Medicine; Xiaoyan Song, MD, Children's National Medical Center; Danielle Zerr, MD, MPH, University of Washington; Rachel C. Orscheln, MD, Washington University School of Medicine; Susan E. Coffin, MD, MPH, Children's Hospital of Philadelphia; Trish M. Perl, MD, MSc, The Johns Hopkins Medical Institutions
3:45 PM
LB 15
MSG-01: A Multicenter, Randomized, Double-Blind, Placebo Controlled Trial of Caspofungin (CAS) Prophylaxis vs Placebo Followed by Pre-Emptive Therapy for Invasive Candidiasis (IC) in High-Risk Adults in the Critical Care Setting. Preliminary Results
Luis Ostrosky-Zeichner, University of Texas Medical School at Houston; Shmuel Shoham, Mycoses Study Group; Jose Vazquez, Mycoses Study Group; Annette Reboli, Mycoses Study Group; Robert Betts, Mycoses Study Group; Michelle Barron, Mycoses Study Group; Mindy Schuster, Mycoses Study Group; Marc A. Judson, Mycoses Study Group; Sanjay Revankar, Mycoses Study Group; Juan Pablo Caeiro, Mycoses Study Group; Julie E. Mangino, Mycoses Study Group; David Mushatt, Mycoses Study Group; Roger Bedimo, Mycoses Study Group; Allison Freifeld, Mycoses Study Group; M. Hong Nguyen, Mycoses Study Group; Carol Kauffman, Mycoses Study Group; Robert A. Larsen, Mycoses Study Group; William E. Dismukes, Mycoses Study Group; Andy O. Westfall, Mycoses Study Group; Jeanna Beth Deerman, Mycoses Study Group; Craig Wood, Merck & Co, Inc; Jack D. Sobel, Mycoses Study Group; Peter G. Pappas, Mycoses Study Group
4:00 PM
LB 16
Bacillus cereus bacteremia associated with contaminated Alcohol Prep Pads: Outbreak investigation followed by international product recall
Susan A. Dolan, RN, MS, CIC, The Children's Hospital; Elaine Dowell, MT, SM(ASCP), The Children's Hospital; Cynthia Littlehorn, MT, SM(ASCP), The Children's Hospital; Mary P. Glodé, MD, The Children's Hospital; James K. Todd, MD, The Children's Hospital; Mary Kate Cichon, BS, Colorado Department of Public Health and Environment (CDPHE); Wendy Bamberg, MD, Colorado Department of Public Health and Environment (CDPHE)